Loading...
MTAA
VLS
Market cap126mUSD
Jul 09, Last price  
10.25EUR
1D
0.00%
1Q
-2.38%
Jan 2017
-35.66%
IPO
130.08%
Name

Valsoia SpA

Chart & Performance

D1W1MN
MTAA:VLS chart
P/E
13.73
P/S
0.94
EPS
0.75
Div Yield, %
3.71%
Shrs. gr., 5y
0.22%
Rev. gr., 5y
7.15%
Revenues
118m
+0.94%
50,643,00054,806,00054,118,00052,294,00056,067,00070,323,00093,308,000100,365,000114,015,000115,316,000114,783,000111,932,00083,501,23974,777,59583,460,54190,953,246101,320,427112,817,925116,751,178117,854,467
Net income
8m
-2.81%
1,996,0003,222,0002,911,0003,588,0003,993,0002,956,0004,490,0009,889,00010,701,00011,978,0008,794,0006,924,00010,097,9607,204,4317,654,1117,364,5117,975,6537,223,9968,275,1458,042,389
CFO
7m
-28.49%
2,263,0004,638,0004,750,0004,117,0004,014,0003,048,0004,895,00019,478,0008,123,00013,714,0009,700,00010,614,00011,302,33811,418,18115,428,11110,989,8868,220,91411,039,42110,221,7907,309,791
Dividend
May 12, 20250.38 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Valsoia S.p.A. is an Italian firm engaged in the manufacturing, distribution, and sale of a broad spectrum of consumer food products, with a primary focus on health-oriented items. Its diverse product range includes plant-based alternatives (notably soy-based), beverages, ice creams, yogurts, desserts, biscuits, ready-to-eat meals, cheeses, condiments, fruit preserves and products, and tomato purees and sauces, alongside various dietary and nutritional supplements. The company markets these goods under a host of brands, including Valsoia Bontà E Salute, Santa Rosa, Valsoia Integratori, Pomodorissimo, Weetabix, Oreo, Vitasoya, Diete.Tic, Piadina Loriana, and Naturattiva. Founded in 1990, Valsoia S.p.A. maintains its headquarters in Bologna, Italy, and functions as a subsidiary of Finsalute S.r.l.
IPO date
Jul 14, 2006
Employees
Domiciled in
IT
Incorporated in
IT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT